The present study was undertaken to formulate and evaluate the anti-inflammatory, anti-oxidant and anti-angiogenic activities of nanoemulsion of Memecylaene. Memecylaene was isolated from the leaves of Memecylon malabaricum by using various chromatographic methods. An oil-in-water (O/W) nanoemulsion of Memecylaene was formulated by sonication method using sunflower oil (oil phase), Tween 80 (Surfactant) and Ethanol (co-surfactant). The prepared nanoemulsion was characterized for its droplet size, poly dispersity index and zeta potential. Stability studies were performed and the nanoemulsions were subjected to different biological activities. The formulated nanoemulsion had a particle size range of 52.02 nm to 59.47 nm and zeta potential of -1.27 mV. The enhanced activity of Memecylaene, encapsulated in O/W emulsions is evidenced by the inhibition of phospholipase (PLA2) enzyme and H + , K + -ATPase and thus showing anti-inflammatory and anti-secretagogues effects. The in vitro anti-oxidant activity was evaluated by DPPH radical and Nitric oxide radical scavenging activity. Further, the inhibition of the growth of neo vessels formation in the in-vivo model system of chick chorioallantoic membrane (CAM) assay, which is angiogenesis dependent, was also observed. The above findings would help in understanding the putative potential of Memecylaene-loaded nanoemulsion as a therapeutic agent.
INTRODUCTION
Memecylon malabaricum is a medicinal plant indigenous to the Western Ghats of India. It is a potent plant material containing a number of bioactive compounds like steroids, triterpenes, flavonoids, saponins, tannins and resins. The leaves are being used as a traditional remedy to cure skin diseases, several stomach disorders, chicken pox, polyuria, menorrhagia and herpes 1 . Memecylaene, 4, 9, 14, 19 -Tetramethyl-1,6,11,16-tetraoxacycloeicosa-3,8,13,19-tetraene plays a promising role as an anti-angiogenic, anti-proliferative, pro-apoptotic, anti-oxidant and anti-inflammatory molecule in vivo and ex vivo experiments 2 . The molecule showed a unique structure simulating crown ethers with promising biological potency. Memecylaene, a highly lipophilic compound, exhibits dissolution related problem and low absorption; therefore, the efficacy may be greatly reduced. Hence, a prospective drug delivery system is essential to enhance the therapeutic index of Memecylaene, by improving its solubilisation property and modifying their
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[127] CODEN (USA): JDDTAO pharmacokinetic profiles. Hence, a unique formulation to alter its physicochemical characteristics is required. The molecule being soluble in sunflower oil to a greater extent, a simple nanoemulsion (NE) system was formulated with no input of high-energy methods, which makes the molecule readily available for transdermal injection.
The design of effective formulations of NE for drugs has always been a major challenge due to severely limited drug efficacy can be of instability or its hydrophobicity. Using nanoparticles (NPs) as drug delivery systems is one of the most promising technologies that are being applied to improve the solubility and bioavailability of hydrophobic drugs. The transport properties of the drug would be influenced by the nanosized droplets that lead to an enormous increase in interfacial areas that are associated with NPs. NEs are unique due to the presence of compartmentalized hydrophobic domains in which both non-polar and polar compounds could be incorporated 3, 4 . There are several reports on plant-based essential oil-derived NE system that have prospective applications in pharmaceuticals 5 . In our current study, a biologically acceptable oil-in-water NE system as molecule delivery vehicle for Memecylaene to improve the efficacy and stability of the drug without the input of high energy methods was optimized. This system is expected to enable easy transport through the smallest capillary vessels without any discrimination by the host defence mechanism and thereby, readily absorbed by the organs.
MATERIALS AND METHOD

Materials
Memecylon malabaricum leaves, Silica gel for column chromatography, Sunflower oil, Tween 80, ethanol, Phosphate Buffer Saline, Omeprazole (Ome), Russell viper venom, Kreb's ringer buffer, 2mM HEPES-Tris, Sucrose-EDTA buffer, fertilized eggs, Butylated hydroxyl toluene (BHT), 1, 1-diphenyl 2-picrylhydrazyl (DPPH).
Methods
Isolation of Memecylaene
The leaves of Memecylon malabaricum collected from the Western Ghats, Karnataka state, India and identified and authenticated by the taxonomist. They were shade dried and coarsely ground. The ground leaves were loaded onto the Soxhlet for extraction, using hexane as the solvent system. The extract was filtered and loaded onto the column packed with silica gel (100-200 mesh) in chloroform and eluted in chloroform. The fraction collected was precipitated using methanol and filtered. Memecylaene was purified from the residue using thin layer chromatography. Thus obtained Memecylaene was used for the preparation of nanoemulsion.
Preparation of nanoemulsion
NE was prepared by the sonication method. 0.1g of Memecylaene was dissolved in 0.5mg of sunflower oil and was added to 2ml of S mix (1:1.5 ratio of Tween 80: Ethanol) in a beaker placed on a magnetic stirrer. Water was simultaneously added drop wise and was left to form a uniform mixture on the magnetic stirrer for a known interval of time. The whole mixture was made to undergo probe sonication for a known interval of time and speed. The formulation table of the prepared NE is given in Table 1 .
Stability studies of the nanoemulsion
Four cycles of the heating-cooling cycle between refrigerator temperature (4°C) and 45°C was conducted, with the storage at each temperature for not less than 48 hours; and the formulation was examined for stability at all these temperatures. The formulation was also centrifuged at 3,500 rpm for 30 minutes and examined for phase separation. The formulation was subjected to four freeze-thaw cycles between -21°C and +25°C and observed for phase separation 6 .
Characterization of the nanoemulsion
Particle size analysis, polydispersity index (PDI) and measurement of surface charge 7 NE formulations were analyzed for particle size and size distribution by Malvern zetasizer. Particle size, size distribution and zeta potential were measured by dynamic light scattering (DLS). Initially, before filtration, higher peaks were found and upon filtration, lower peaks were observed. Zeta potential (ζ) measurements of the NE formulations were performed using Malvern zetasizer.
Visual characterization:
The NE was investigated for the presence of structures visible to the eye as well as for its texture.
Assay of phospholipase A2 (PLA2) by indirect hemolytic method
PLA2 activity was carried out by using an indirect hemolytic method of Boman HG and Kaletta 8 .Briefly, the packed human erythrocytes, egg yolk and phosphate buffered saline (1:1:8 V/V) were mixed accordingly. 1ml of this suspension was incubated separately with 60 µg of V. russelli venom for 10 min at 37 o C; the reaction was stopped by adding 10 ml of ice-cold phosphate buffer saline and centrifuged at 4 o C for 10 min at 800×g. The amount of hemoglobin released into the supernatant was measured at 540 nm. The assay was also carried out in the presence of various concentrations 2, 4,6, 8 and 10 μg of NE. Lysis of erythrocytes by adding 9 ml of distilled water to the control reaction mixture was taken as 100% 9 .
Gastric H + /K + -ATPase activity
ATPase activity was determined as described by Im et al. 10 . Basal Mg 2+ dependent ATPase activity was measured in 1.0 ml of the reaction medium consisting of 2 mmol/l ATP and 50 mmol/l Tris-HCl buffer (pH 7.5), K + -stimulated and HCO 3 -stimulated. ATPase activity was defined as the activity in the basal medium. The ATPase reaction was started by the addition of the substrate (ATP), carried out at 37˚C for 15 minutes and stopped with 1.0 ml ice-cold 20% Tri Chloro Acetic acid (TCA), liberated inorganic phosphate from ATP was estimated by Tsai method 11 .
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All experiments were repeated in triplicates in three independent sets. The assay was also carried out in the presence of various concentrations 2, 8 and 10 μg of NE. Percent inhibition was calculated by the comparison of the inhibition by NE with that of the drug Omeprazole (Ome) taken as a standard compound. The concentration of test compound causing 50% inhibition (IC50, µg/ml) was calculated from the concentration-inhibition response curve.
Anti-oxidant studies
DPPH radical scavenging assay DPPH radical scavenging activity was carried out as previously reported by Lingappa Mallesha et al. 12 . Briefly, different aliquots of NE; 2, 4, 6 and 8µg was mixed with 1 ml of DPPH solution (0.1 mM in 95% ethanol) under vigorous shaking. The mixture was allowed to stand for 20 minutes at room temperature and following this, absorbance was measured at 517 nm with a UV-VIS spectrophotometer (HITACHI, U-2900). Radical scavenging potential was expressed as an IC50 value, i.e., the concentration at which DPPH radicals were scavenged up to 50%. As a positive control for DPPH radical scavenging assay, BHT was used.
Nitric oxide radical scavenging activity
Griess reaction was used to measure the nitric oxide generated from sodium nitroprusside. It has been shown that nitric oxide is generated when sodium nitroprusside is introduced in phosphate buffer at physiological pH 13 . Griess reagent is used to estimate the nitrate ion produced by the reaction between nitric oxide and oxygen. The nitric oxide radical scavenging activity was carried out according to Lingappa Mallesha et al. 12 with slight modifications. Briefly, reduced production of nitric oxide can be seen when the nitric oxide scavengers compete with oxygen. Different aliquots of NE; 3,6,9,12 and 15μg was taken and mixed with sodium nitroprusside (5mM) in phosphate buffered saline and this mixture was incubated at 25°C for 3 hours. The absorbance was read against BHT that was treated the same way with the Griess reagent at 546 nm for the color formed during the diazotization of sulphanilamide with nitrite and coupling subsequently with naphylethylenediamine.
Angioinhibitory effect by Shell-less chorioallantoic membrane (CAM) assay
Shell-less chorioallantoic membrane assay is an angiogenic assay used for the validation of angioinhibitory activity of any given compound. The CAM assay, to note the anti-angiogenic activity was performed using the NE of Memecylaene. The antiangiogenic effect was studied according to the method reported by Bushra Begum et al.
14 with slight modifications. Briefly, surface sterilization of fertilized hen's eggs was done using 70% alcohol. Fan assisted humidified incubator at 37°C was used to incubate the eggs. Within a laminar air flow, 4 day old eggs were cracked out into thin films of the hammock and these eggs were further incubated. Proliferating blood vessels were seen from the center of the eggs within the hammock on the 5 th day; later, over these proliferating blood vessels, the filter paper discs loaded with 5 µg of Memecylaene NE were placed and the eggs were incubated again. Results for the anti-angiogenic effect of the molecule were observed after 24 hours of incubation. 
RESULTS AND DISCUSSION
Stability studies of the nanoemulsion
After the heating-cooling cycle, centrifugation test and freeze-thaw cycle, no phase separation was seen in the prepared NE. There were no sediments and hence the NE was found to be stable (Fig. 1) .
Characterization of the nanoemulsion
Particle size analysis, polydispersity index (PDI) and measurement of surface charge
Upon scanning, the size of the blank NE was found to be in the range of 11.55nm to 11.65 nm; and that of the drug-loaded NE was found to be in the range of 52.02 nm to 59.47 nm. The PDI of the blank NE was found to be 0.400 and that of the drug-loaded NE was found to be 0.990. Zeta potential of the blank NE was found to be -1.23 mV and that of the drug-loaded NE was found to be -1.27 mV. 
Visual characterization
The formulation had a visually appealing, homogeneous appearance which was retained over the observation period of two months. The formulated NE had a transparent pale yellow appearance, which in turn fulfils its criteria of being an NE.
Assay of phospholipase A2 by indirect hemolytic method
Inhibition of Russell viper venom PLA2by NE was dose-dependent with an IC50 value of 8.92µg/ml ( Fig.2A) . The percentage of PLA2 enzyme that causes inflammation inhibition increased with the increased concentration of the NE.
Gastric (H + K + ) ATPase inhibition
The enzyme was collected from the fundic region of the sheep and was stored in the sucrose EDTA buffer. ATPase activity in various gastric membranes was determined. The liberated inorganic phosphate from ATP was estimated by Tsai method
11
. The NE was compared with the standard drug Omeprazole, and the NE inhibited (H + -K + ) ATPase to a greater extent compared with the standard drug. The inhibition of ATPase was dose-dependent (Fig.2B) . The NE showed an IC50 value of 6.57µg/ml compared to that of the reference drug omeprazole with an IC50value of 9.32µg/ml.
Anti-oxidant studies
DPPH radical scavenging assay
One of the characteristic properties of natural antioxidants is their ability to scavenge free radicals. DPPH scavenging assay is used to quantify protonradical scavenging action of antioxidant. DPPH has absorbance maxima of 517 nm. In the presence of an antioxidant, the absorbance maxima decrease as scavenging of proton-radical take place 15 . Free radical scavenging potential is demonstrated by the ability of the DPPH molecule to donate hydrogen. NE shows DPPH radical scavenging activity due to its hydrogen donating capacity. In this work, DPPH radical scavenging activity of Memecylaene loaded NE had an IC50 value of 5.13µg/ml and comparable with the IC50 value of 4.36µg/ml for BHT (Fig.3A) . DPPH antioxidant activity of the NE was compared to the reference compound BHT and the NE showed an increased radical scavenging activity as the concentration was increased.
Nitric oxide radical scavenging activity
NE's of both Memecylaene and BHT showed a significant nitric oxide radical scavenging activity. Sodium nitroprusside generated nitric oxide at the physiological pH was inhibited by NE of Memecylaene with an IC50 value of 3.6µg/ml and BHT with an IC50 value of 3.84µg/ml. The result reveals that the NE and BHT are almost similar in their potency in scavenging the nitric oxide radicals (Fig.3B) .
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Angio-inhibitory effect by Shell-less chorioallantoic membrane (CAM) assay
The angio-inhibitory activity of the NE is as shown in the (Fig.4A) ; exhibited significant positive results in the shell-less CAM assay model of developing embryos. The data shown represent the results using a minimum of six eggs in each group. The investigation of antiangiogenic activity of NE of Memecylaene (Fig.4B) showed a significant reduction of proliferation of capillaries around the zone of application of the discs loaded with the 5µg of NE. These results indicate that the NE forms a potent anti-angiogenic agent in vivo.
Memecylon malabaricum is a potent plant material containing a number of bioactive compounds like steroids, triterpenes, flavonoids, saponins, tannins and resins. The methanolic extract of the plant is reported to have anti-microbial activity 16 and anti-diabetic activity 17 . According to the literature, the solubility of Memecylaene molecule was difficult due to its hydrophobic nature and therefore, an effort was made to prepare an NE to increase its solubility and to assess its biological activities.
The results of all these studies suggest that NE is a promising novel formulation that can enhance the solubility of Memecylaene, comprising of Memecylaene and sunflower oil in the oil phase, Tween 80 and ethanol in the water phase. Thus, the nano droplets comprised of the hydrophobic molecule 'Memecylaene', surrounded by surfactant and co-surfactant (S mix ).
CONCLUSION
NE was prepared to increase the solubility of Memecylaene, a hydrophobic molecule which was isolated from Memecylon malabaricum was found to be a potent biologically active molecule which can be used as a readily available drug for transdermal delivery. Through proper selection of all the critical components required for the synthesis of NE, stable drug-loaded NE was prepared. NE, to date, have been shown to be able to protect labile drugs, control its release, increase the bioavailability, reduce patient variability and increase drug solubility. The results of these studies indicate the potential role of O/W type of NE for enhancing the solubility of the hydrophobic molecule Memecylaene. The reduction of pro-inflammatory biomarkers and an increase in antioxidant activity with inhibition of PLA2 shown by Memecylaene is a proof for its anti-inflammatory activity. We are reporting in our study that NE of Memecylaene forms an excellent biocompatible drug delivery system comprised of sunflower oil, Tween 80 and water for the solubilisation of poorly water-soluble Memecylaene. The Memecylaene was found to be highly solubilized in sunflower oil ranging about 10 mg/ml. Further, when incorporated into the oil core of the NE system, the drug degradation factor is greatly reduced and it maintained a good thermodynamic stability with better drug-loading capacity. Moreover, the particle size reduction of the drug to nanometres range would significantly improve the dissolution rate and thereby improve the bioavailability of the molecule in in-vivo after administration. Thus, the therapeutic efficacy of the drug would be enhanced to meet the patient's need. Also, the development of NE formulation of Memecylaene with optical clarity and low-viscosity involving no high-energy methods would be of interest to pharmaceutical scientists.
